SCHEMBL7225116

SCHEMBL7225116

FC(F)(F)c1cc(-c2ccco2)c2cccc(C(F)(F)F)c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.45
HSD17B10 Q99714 4/20 0.45
HPGD P15428 4/20 0.45
ALDH1A1 P00352 3/20 0.45
HTT P42858 3/20 0.45
TLR8 Q9NR97 2/20 0.45
TP53 P04637 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
JAK2 O60674 1/20 0.45
MAPT P10636 1/20 0.45
STAT3 P40763 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PIK3R1 P27986 2/20 0.43
PIK3CA P42336 2/20 0.43
TSHR P16473 5/20 0.43
CYP2D6 P10635 2/20 0.41
ADORA2A P29274 5/20 0.41
ADORA1 P30542 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7221651 0.78 PDE4D (0.46) KDM4EHTTTP53TSHRCYP2D6
SCHEMBL7221654 0.76 ESR1 (0.41) KDM4EALDH1A1HTTTP53TSHR
SCHEMBL7689636 0.75 KCNH2 (0.46) KDM4EALDH1A1HTTTP53TSHR
SCHEMBL7218903 0.74 KCNH2 (0.53) KDM4EHSD17B10HPGDALDH1A1HTT
SCHEMBL1258312 0.73 KCNH2 (0.47) KDM4EALDH1A1HTTTP53TSHR
SCHEMBL2790280 0.73 ALDH1A1 (0.48) KDM4EALDH1A1HTTTP53TSHR
SCHEMBL2790491 0.72 KCNH2 (0.46) KDM4EALDH1A1HTTTP53TSHR
SCHEMBL2608426 0.72 CYP2D6 (0.46) KDM4EALDH1A1HTTTP53TSHR
SCHEMBL1655812 0.72 KCNH2 (0.49) KDM4EALDH1A1HTTTP53TSHR
SCHEMBL30604781 0.72 KCNH2 (0.46) KDM4EALDH1A1HTTTP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583156-B1 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol VERNALIS RESEARCH LIMITED (GB) 2003-06-24 US disclosed
EP-1107760-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2001-06-20 EP disclosed
WO-2000013681-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2000-03-16 WO disclosed